OpenFilings

Immix Biopharma, Inc.

Form10-K

Report Period2022-12-31

Date Filed2023-03-27

Time Filed16:15:58

Document Analysis

Natural Language Processing

Recognized Type Unidentified

Defined Term Format

Exhibits

Filing on SEC Edgar